Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 541-548

  Yang, Xiaoxiao ^a   Li, Shifeng ^a   Li, Wande ^b   Chen, Jingkao ^a   Xiao, Xiao ^a   Wang, Youqiong ^a   Yan, Guangmei ^a   Chen, Lijun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aminopropionitrile; Cervical cancer; Epithelial mesenchymal transition; Invasion and migration; Lysyl oxidase

Indexed keywords

3 AMINOPROPIONITRILE; ALPHA SMOOTH MUSCLE ACTIN; PROTEIN LYSINE 6 OXIDASE; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CATALYSIS; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CARCINOMA;

ACTINS; AMINOPROPIONITRILE; ANOXIA; CADHERINS; CELL MOVEMENT; ENZYME INHIBITORS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HELA CELLS; HUMANS; NEOPLASM INVASIVENESS; PROTEIN-LYSINE 6-OXIDASE; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; VIMENTIN;

EID: 84872799462     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2146     Document Type: Article

References (44)

1. Sobti RC, Singh N, Hussain S, Suri V, Nijhawan R, Bharti AC, Bharadwaj M and Das BC: Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis. Cell Oncol 34: 533-543, 2011.
2. Chandra S, Barola N and Bahadur D: Impedimetric biosensor for early detection of cervical cancer. Chem Commun 47: 11258-11260, 2011.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Qiang R, Wang F, Shi LY, Liu M, Chen S, Wan HY, Li YX, Li X, Gao SY, Sun BC and Tang H: Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 43: 632-641, 2011.
5. Ng MR and Brugge JS: A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell 16: 455-457, 2009.
6. Trackman PC, Bedell-Hogan D, Tang J and Kagan HM: Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem 267: 8666-8671, 1992.
7. Zhao Y, Chen L, Gao S, Toselli P, Stone P and Li W: The critical role of the cellular thiol homeostasis in cadmium perturbation of the lung extracellular matrix. Toxicology 267: 60-69, 2010.
8. Viguet-Carrin S, Garnero P and Delmas PD: The role of collagen in bone strength. Osteoporos Int 17: 319-336, 2006.
9. Smith-Mungo LI and Kagan HM: Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 16: 387-398, 1998. (Pubitemid 28069865)
10. Kagan HM and Li W: Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88: 660-672, 2003. (Pubitemid 36258816)
11. Ferns GA, Lamb DJ and Taylor A: The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 133: 139-152, 1997. (Pubitemid 27373491)
12. Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia J F, Guadall A and Badimon L: Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res 79: 7-13, 2008. (Pubitemid 351881945)
13. Jeay S, Pianetti S, Kagan HM and Sonenshein GE: Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol Cell Biol 23: 2251-2263, 2003. (Pubitemid 36351009)
14. Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, Kanitakis J, Perrier E, Damour O and Sommer P: The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin Cancer Res 12: 1463-1469, 2006.
15. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, Trackman PC and Sonenshein GE: The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 67: 1105-1112, 2007.
16. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT and Giaccia AJ: Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44, 2009.
17. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL and Weaver VM: Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906, 2009.
18. Erler JT and Giaccia AJ: Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 66: 10238-10241, 2006. (Pubitemid 44799737)
19. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226, 2006.
20. Brown JM and Wilson WR: Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437-447, 2004. (Pubitemid 38745529)
21. Vaupel P, Kelleher DK and Hockel M: Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28: 29-35, 2001. (Pubitemid 32522235)
22. Wilson WR and Hay MP: Targeting hypoxia in cancer therapy. Nat Rev Cancer 11: 393-410, 2011.
23. Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105: 6392-6397, 2008. (Pubitemid 351758356)
24. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006. (Pubitemid 44050139)
25. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
26. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005. (Pubitemid 41267170)
27. Erler JT, Cawthorne CJ, Williams KJ, Koritzinsky M, Wouters BG, Wilson C, Miller C, Demonacos C, Stratford IJ and Dive C: Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol 24: 2875-2889, 2004. (Pubitemid 38381277)
28. Chen LJ, Zhao Y, Gao S, Chou IN, Toselli P, Stone P and Li W: Downregulation of lysyl oxidase and upregulation of cellular thiols in rat fetal lung fibroblasts treated with cigarette smoke condensate. Toxicol Sci 83: 372-379, 2005. (Pubitemid 40227907)
29. Chou DK, Zhao Y, Gao S, Chou IN, Toselli P, Stone P and Li W: Perturbation of copper (Cu) homeostasis and expression of Cu-binding proteins in cadmium-resistant lung fibroblasts. Toxicol Sci 99: 267-276, 2007. (Pubitemid 47250384)
30. Palamakumbura AH and Trackman PC: A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 300: 245-251, 2002. (Pubitemid 34093700)
31. Chen LJ, Li WD, Li SF, Su XW, Lin GY, Huang YJ and Yan GM: Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts. Acta Pharmacol Sin 31: 554-559, 2010.
32. Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y, Xie J, He S, Qiu P and Yan G: A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol 75: 812-819, 2009.
33. Hollosi P, Yakushiji JK, Fong KS, Csiszar K and Fong SF: Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. Int J Cancer 125: 318-327, 2009.
34. Erler JT and Weaver VM: Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26: 35-49, 2009.
35. Brahimi-Horn C, Mazure N and Pouyssegur J: Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17: 1-9, 2005. (Pubitemid 39286774)
36. Wang V, Davis DA, Haque M, Huang LE and Yarchoan R: Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65: 3299-3306, 2005. (Pubitemid 40524614)
37. Pez F, Dayan F, Durivault J, Kaniewski B, Aimond G, Le Provost GS, Deux B, Clezardin P, Sommer P, Pouyssegur J and Reynaud C: The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res 71: 1647-1657, 2011.
38. Payne SL, Hendrix MJ and Kirschmann DA: Paradoxical roles for lysyl oxidases in cancer - a prospect. J Cell Biochem 101: 1338-1354, 2007. (Pubitemid 47242767)
39. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
40. Tepass U, Truong K, Godt D, Ikura M and Peifer M: Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 1: 91-100, 2000.
41. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166: 1321-1332, 2005. (Pubitemid 40586504)
42. Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC, Yang RB, Hong TM and Yang PC: SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene 30: 3682-3693, 2011.
43. Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK, Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 71: 7061-7070, 2011.
44. Li W, Liu G, Chou IN and Kagan HM: Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J Cell Biochem 78: 550-557, 2000. (Pubitemid 30620701)